Anaspec.com - Anaspec Inc Company News Section

Anaspec Inc Press Release -

Anaspec.com

  • AnaSpec Offers Special Pricing for MOG (1-125) Recombinant Proteins
  • Myelin Oligodendrocyte Glycoprotein (MOG), a 26- to 28-kDa protein, is a member of the immunoglobulin superfamily. It is expressed exclusively in the central nervous system (CNS), specifically on the surface of myelinating oligodendrocytes and external lamellae of myelin sheath.
  • February 14, 2012
  • AnaSpec Developes AMC Resins for SPPS
  • AnaSpec, EGT Group has developed a novel solid support AMC resin for facile solid-phase synthesis of peptide-AMCs. As result, N-Fmoc-7-aminocoumarin-4-acetic acid (Fmoc-Aca-OH) is attached to Wang resin as a linker.
  • February 14, 2012
  • AnaSpec Expands SensoLyte(R) 520 Renin Assay Kits Collection
  • Using our proprietary 5-FAM/QXL™ 520 fluorescence resonance energy transfer (FRET) peptide, SensoLyte® 520 Renin Assay Kits are ideal for screening of renin inhibitors and for continuous assay of renin activity, especially for high throughput screening (HTS) purposes.
  • January 25, 2012
  • AnaSpec Introduces SensoLyte(R) Deubiquitination Assay Kit
  • AnaSpec, EGT Group, is pleased to introduce the SensoLyte® 440 Deubiquitination Assay Kit. SensoLyte® 440 Deubiquitination Assay Kit provides a convenient assay for inhibitors/activators screening in deubiquitinylation or for continuous assay of enzyme activity.
  • December 13, 2011
  • AnaSpec Offers Monoclonal Antibody, Anti-5-Methylcytidine
  • 5-Methylcytidine is a modified base found in the DNA of plants and vertebrate. DNA methylation is a post-replication process involved in the establishment of genomic imprinting, in the control of gene expression and of differentiation.
  • August 16, 2011
  • AnaSpec Highlights Anb-Wang Resin
  • Chemists at AnaSpec, Eurogentec Group have developed a Wang resin conjugated with a pNA analog, 5-amino-2-nitrozenzoic acid (Anb5,2).
  • June 29, 2011
  • AnaSpec Introducing DPPIV Assay Kit
  • AnaSpec's new SensoLyte® Rh110 DPPIV Assay Kit provides a convenient assay for enzyme inhibitors and activators screening or for the continuous assay of enzyme activity.
  • May 27, 2011
  • AnaSpec Introduces Anti- β-Amyloid
  • Two new mouse monoclonal antibodies specific for β-Amyloid (1-40) & (1-42) are of the IgG1 subtype and do not cross-react with each other at concentrations up to 50 ng/ml when tested in sandwich ELISA.
  • April 28, 2011
  • AnaSpec Introduces Dipeptide Library
  • Dipeptide and tripeptide libraries can be systematically constructed to contain almost all possible combinations of the 20 common amino acids.
  • April 20, 2011
  • AnaSpec Offers α & β-Synuclein Recombinant Proteins
  • AnaSpec, Eurogentec Group, is pleased to offer two recombinant proteins for use in Neurodegenerative Disease Research, α-synuclein (SNCA) and β-synuclein (SNCB). Both α-synuclein and β-synuclein are expressed and purified from E. coli.
  • February 18, 2011
  • AnaSpec Introduces Industry's First Fluorimetric Assay - SensoLyte(R) Cathepsin G Kits
  • AnaSpec, Eurogentec Group, is pleased to announce the release of the industry's first fluorimetric kits for Cathepsin G, the SensoLyte® 520 Cathepsin G Assay Kit and SensoLyte® Rh110 Cathepsin G Assay Kit. These long-wavelength, homogeneous assays are ideal for the screening of enzyme inhibitors and activators or for continuous assay of Cathepsin G activity.
  • February 15, 2011
  • AnaSpec Expands HCV NS3/4A Protease Selection
  • AnaSpec, Eurogentec Group is pleased to announce the expansion of our NS3/4A protease selection to include proteases from genotypes 1a, 1b, 2a, 3a and 4d. These recombinant HCV NS3/4A proteases are highly active and can be used with the SensoLyte® 490, 520, or 620 HCV Protease Assay Kits for screening of anti-HCV protease drugs.
  • December 10, 2010
  • AnaSpec Introduces Anti-MOG (1-125), Mouse Monoclonal
  • Being the first in the industry to provide a whole suite of reagents and assay kits for the advancement of MS research, AnaSpec is pleased to announce the release of the mouse monoclonal Anti-MOG (1-125).
  • November 19, 2010